Archived Bulletins

March 14, 2018

Published: March 14, 2018
Category: Group updates

On-line Registration is now open. Travel and hotel information, a draft Schedule of Events, and our meetings policies, including the Invitation Policy, Registration Policy, and Travel Reimbursement Policy, are posted on the Spring Meeting 2018 Registration and Information page.

Read More

Shakeel Virk Director Operations & Pathology Coordinator & Dr Lois Shepherd Director of the #CCTG Tumour Tissue Data Repository with Dr David LeBrun, Academic Director, Queen's Canada Laboratory for Molecular Pathology

Queen's University played host to a research funding announcement with Dr. John Fisher, Vice-Principal (Research), Queen’s University and Ms. Sophie Kiwala, MPP for Kingston and the Islands. Along with a number of awards, it was announced that CCTG has received matching infrastructure funding from The Ontario Research Fund to support the purchase of a histology slide scanner.

Read More

Published: March 14, 2018
Category: Publications
Primary Publication for CEC3 (NCCTG N107C) - A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease Read More

February 28, 2018

Published: February 28, 2018
Category: Trials

"POSITIVE" (CCTG MAC18 / ALLIANCE A221405) is a unique trial which is collecting information prospectively on disease and pregnancy outcome after interrupting endocrine therapy in women with endocrine responsive early breast cancer who wish to have a baby. The lead group have r

Read More

Published: February 28, 2018
Category: Group updates

The Canadian Cancer Trials Group (CCTG), as a major stakeholder, has been invited to provide input on the Health Canada draft of GUI-0100: Guidance Document - Part C, Division 5 of the Food and Drug Regulations "Drugs for Clinical Trials Involving Human Subjects." As a valued member of CCTG we would like to request your input to the CCTG response.

Read More

February 14, 2018

Published: February 14, 2018
Category: Trials

CCTG clinical trials IND213, LY15 and MA31 have been permanently closed.

Read More

Published: February 14, 2018
Category: Group updates
The 2018 Annual Spring Meeting of Participants

The 2018 Annual Spring Meeting of Participants is happening the weekend of April 27 – 29 at the Chelsea Hotel in Toronto. Funded and non-funded invitations are coming soon.

Read More

Published: February 14, 2018
Category: Publications
CCTG trials listed in research publications or citations